1. Home
  2. UPB vs USAS Comparison

UPB vs USAS Comparison

Compare UPB & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPB
  • USAS
  • Stock Information
  • Founded
  • UPB 2021
  • USAS 1998
  • Country
  • UPB United States
  • USAS Canada
  • Employees
  • UPB N/A
  • USAS N/A
  • Industry
  • UPB
  • USAS Metal Mining
  • Sector
  • UPB
  • USAS Basic Materials
  • Exchange
  • UPB NYSE
  • USAS Nasdaq
  • Market Cap
  • UPB 521.3M
  • USAS 536.1M
  • IPO Year
  • UPB 2024
  • USAS N/A
  • Fundamental
  • Price
  • UPB $11.49
  • USAS $1.02
  • Analyst Decision
  • UPB Strong Buy
  • USAS Strong Buy
  • Analyst Count
  • UPB 4
  • USAS 1
  • Target Price
  • UPB $56.50
  • USAS $1.30
  • AVG Volume (30 Days)
  • UPB 496.2K
  • USAS 2.0M
  • Earning Date
  • UPB 08-14-2025
  • USAS 08-14-2025
  • Dividend Yield
  • UPB N/A
  • USAS N/A
  • EPS Growth
  • UPB N/A
  • USAS N/A
  • EPS
  • UPB N/A
  • USAS N/A
  • Revenue
  • UPB $2,296,000.00
  • USAS $102,883,000.00
  • Revenue This Year
  • UPB N/A
  • USAS $45.78
  • Revenue Next Year
  • UPB N/A
  • USAS $17.98
  • P/E Ratio
  • UPB N/A
  • USAS N/A
  • Revenue Growth
  • UPB N/A
  • USAS 8.12
  • 52 Week Low
  • UPB $5.14
  • USAS $0.21
  • 52 Week High
  • UPB $29.46
  • USAS $1.05
  • Technical
  • Relative Strength Index (RSI)
  • UPB N/A
  • USAS 76.51
  • Support Level
  • UPB N/A
  • USAS $0.80
  • Resistance Level
  • UPB N/A
  • USAS $0.90
  • Average True Range (ATR)
  • UPB 0.00
  • USAS 0.06
  • MACD
  • UPB 0.00
  • USAS 0.01
  • Stochastic Oscillator
  • UPB 0.00
  • USAS 90.91

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

Share on Social Networks: